Three-dimensional computer modeling in reconstructive surgery of locally advanced lung cancer
Abstract
Objective. The mail aim of the report is to demonstrate the effectiveness of three-dimensional (3D) modeling in preoperative planning, quality control and monitoring of the operated structures condition after a complex tracheobronchoangioplasty for centrally located lung cancer.
Materials and methods. A 67-year-old patient undergone a complex parenchyma-sparing reconstructive surgery on the lung. Operation planning was carried out on the 3D models, which had been built with the help of 3D Slicer software product based on chest CT scans. Quality control of the operation was implemented intraoperatively by comparing the removed specimen with its model. Monitoring of the operated structures was conducted by analyzing 3D models constructed on the basis of postoperative studies.
Results. The operation was performed strictly in accordance with the plan. The postoperative course was uneventful. The observation period constituted 18 months. Signs of the disease progression were not detected; arterial and bronchial anastomoses are permeable. An increase in the operated lung was noted.
Conclusion. 3D modeling is an effective tool in terms of preoperative planning, quality control and monitoring of the operated structures after complex tracheobronchoangioplasty for centrally located lung cancer.
About the Authors
S. A. Yeskov
РНПЦ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
S. A. Krasny
РНПЦ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
V. T. Malkevich
РНПЦ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
Y. A. Savich
РНПЦ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
References
1. Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 18S countries. CA: A Cancer Journal for Clinicians. 2018; 68 (6): 394—424.
2. Gorenstein L. A., Sonett J. R. The surgical management of stage i and stage II lung cancer. Surg. Oncol. Clin. N. Am. 2011; (20): 701—20.
3. Ma Q. L., Guo Y.-Q., Shi B. et al. For non-small cell lung cancer with T3 (central) disease, sleeve lobectomy or pneumonectomy? J. Thorac. Dis. 2016; (8): 1227—33.
4. Melloul E., Egger B., Krueger Th. et al. Mortality, complications and loss of pulmonary function after pneumonectomy vs. sleeve lobectomy in patients younger and older than 70 years. Interact Cardiovasc Thorac Surg. 2008; (7): 986—8.
5. Riquet M., Mordant P, Pricopi C. et al. A review of 2S0 ten-year survivors after pneumonectomy for non-small-cell lung cancer. Eur. J. Cardiothorac Surg. 2014; (4S): 876—81.
6. Deslauriers J., Gregoire J., Jacques L. F. et al. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. The Annals of Thoracic Surgery. 2004; (77): 11S2—6.
7. Wang S., Wang X., Zhou Q. et al. Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review. Thorac Cancer. 2018; (9): 337—47.
8. Nagayasu T., Yamasaki N., Tsuchiya T. et al. The evolution of bronchoplasty and broncho-angioplasty as treatments for lung cancer: Evaluation of 30 years of data from a single institution. Eur. J. Cardiothorac. Surg. 2016; (49): 300—6.
Review
For citations:
Yeskov S.A., Krasny S.A., Malkevich V.T., Savich Y.A. Three-dimensional computer modeling in reconstructive surgery of locally advanced lung cancer. Healthcare. 2024;(1):52-59. (In Russ.)
Views:
10
Email this article 